language English
YI

Yagci, Ilker

6 yayın · 23 atıf · 2021–2026

Yayın
6
Atıf
23
Yıllar
5
Yayınlar
Başlık Yıl Tip Atıf
Prevalence and risk factors of difficult-to-treat axial spondyloarthritis: Real-life evidence from the BioSTaR database
CLINICAL RHEUMATOLOGY
2026 Article 0
The impact of obesity and overweight on rheumatoid arthritis patients: real-world insights from a biologic and targeted synthetic DMARDs registry
RHEUMATOLOGY INTERNATIONAL
2025 Article 2
Real-life data on the comorbidities in spondyloarthritis from our multicenter nationwide registry: BioStar
ARCHIVES OF RHEUMATOLOGY
2023 Article 10
Demographic and Clinical Characteristics of Patients with Sustained and Switching Treatments Using Biological and Targeted Synthetic Disease-Modifying Antirheumatic Drugs: A Multicenter, Observational Cross-Sectional Study for Rheumatoid Arthritis
RHEUMATOLOGY AND THERAPY
2022 Article 3
Where we are in treat to target era? Predictive factors for remission and drug switching in patients with axial spondyloarthritis: a real-life evidence from BioStaR nationwide registry
CLINICAL RHEUMATOLOGY
2022 Article 3
Clinical performance of rheumatoid arthritis impact of disease score: a real-life evidence from the multicenter nationwide registry BioStaR
RHEUMATOLOGY INTERNATIONAL
2021 Article 5